Latest news with #OSRHoldings
Malaysian Reserve
01-08-2025
- Business
- Malaysian Reserve
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting. Event Details Date: Wednesday, August 6, 2025Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KSTLocation: Virtual (livestream access)Registration: Opens Monday, August 4 at Available after the event on the OSR Holdings Investor Relations website. Agenda Highlights Corporate overview and strategic vision Subsidiary and R&D pipeline updates: Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM Equity Line of Credit (ELOC) financing strategy Blockchain & Tokenization strategy Live Q&A with management Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM 'This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth,' said Peter Hwang, CEO of OSRH. 'We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months.'Featured Speakers: Mr. Peter Hwang – Chief Executive Officer Dr. Constance Höfer – Chief Scientific Officer Mr. Tim Smith – Global Investor Relations About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit
Yahoo
01-08-2025
- Business
- Yahoo
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting. Event Details Date: Wednesday, August 6, 2025Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KSTLocation: Virtual (livestream access)Registration: Opens Monday, August 4 at Available after the event on the OSR Holdings Investor Relations website. Agenda Highlights Corporate overview and strategic vision Subsidiary and R&D pipeline updates: Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM Equity Line of Credit (ELOC) financing strategy Blockchain & Tokenization strategy Live Q&A with management "This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth," said Peter Hwang, CEO of OSRH. "We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months."Featured Speakers: Mr. Peter Hwang – Chief Executive Officer Dr. Constance Höfer – Chief Scientific Officer Mr. Tim Smith – Global Investor Relations About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit View original content to download multimedia: SOURCE OSR Holdings Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
28-07-2025
- Business
- Yahoo
OSR Holdings to acquire South Korea's medical device company Woori IO
Healthcare business OSR Holdings (OSRH) has signed a term sheet to acquire South Korea's medical device company, Woori IO (WORIO). Under the agreement, WORIO will be acquired by OSRH's Korean affiliate, OSR Holdings Co., Ltd (OSRK). WORIO will become OSRK's wholly owned subsidiary, with the shareholders of the former receiving new OSRK shares. These shares may be convertible into OSRH common stock on Nasdaq, subject to a $10 per OSRH share condition and other terms. WORIO shareholders have the option of converting their OSRK shares into OSRH shares at a fixed ratio. This conversion is contingent upon OSRH's stock price, hitting a minimum of $10.00 at any point within three years after the term sheet is executed. Should this price target not be achieved within the specified timeframe, both parties are committed to entering into renegotiations. A six-month exclusivity period is part of the agreement, during which OSRK will carry out confirmatory legal and financial due diligence. The goal is to conclude the acquisition within this timeframe. Via its subsidiaries, OSRH is involved in various healthcare sectors, including regenerative biologics, immuno-oncology, and the distribution of medical devices. OSRH CEO Peter Hwang said: "We believe this initial milestone with Woori IO aligns strongly with our mission to accelerate breakthrough healthcare innovations with global impact. "Woori IO's breakthrough noninvasive glucose monitoring platform, coupled with its high-profile partnership with global companies, puts OSRH in a position to become a first mover in this fast-growing global market." WORIO's platform is said to leverage near-infrared spectroscopy (NIRS) for the measurement of glucose levels, eliminating the need for finger pricks from diabetes patients. The technology has already undergone a proof-of-concept trial with the Korea University Hospital (Guro) to validate its prototype devices. WORIO is preparing for a larger confirmatory study to seek approval from the Korean Ministry of Food and Drug Safety (MFDS). The company's technology is also seen as a potential addition to wearable glucose monitoring devices such as smartwatches. "OSR Holdings to acquire South Korea's medical device company Woori IO" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Associated Press
08-07-2025
- Business
- Associated Press
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
BELLEVUE, Wash. and ZUG, Switzerland, July 8, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the official roadmap for a targeted $50 million security token offering (STO) planned for launch in the second half of 2025 under Regulation D of the U.S. Securities Act. The token, with the working title OSRT, will be a securitized digital asset representing OSR Holdings' equity exposure and is designed to align with the company's blockchain-based capital strategy. As part of this roadmap, Taekwondo Access Credit (TAC)—a utility token that rewards participation and has growing adoption in the global Taekwondo community —will be accepted alongside Bitcoin (BTC) and Tether (USDT) as eligible currencies for subscription to the OSRT offering. Taekwondo remains one of the world's most widely practiced martial arts, with an estimated 70 million practitioners of all ages across 190 countries. BCM Europe intends to convert a substantial portion of its TAC holdings into BTC or USDT through market-based transactions prior to its anticipated participation. Due to the convertibility of TAC into OSRT and to ensure compliance and mitigate potential insider trading concerns, BCM Europe AG, the issuer of TAC and the largest shareholder of OSR Holdings, will not be permitted to use TAC directly in subscribing to the OSRT offering. Other interested and eligible subscribers of OSRT will be able to use BTC, USDT, or TAC to acquire OSRT tokens. 'Our upcoming STO is not just a tokenization of our equity – it's a foundational element of our long-term capital and treasury strategy,' said Peter Hwang, CEO of OSR Holdings. 'We believe that our combined $50 million STO plan and $80 million equity line of credit (ELOC) from White Lion GBM Innovation Fund provides a credible and achievable path towards building a $100 million Bitcoin and USDT reserve on our balance sheet.' Key Elements of the OSRT Security Token Roadmap: 'This roadmap represents a significant evolution in how public healthcare companies can engage with digital finance,' said Chris Bang, Chief Financial Officer of OSR Holdings. 'By structuring this offering with both transparency and accessibility in mind, we aim to reach a new generation of investors while maintaining regulatory discipline and operational integrity.' About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development. For more information, visit About BCM Europe AG BCM Europe AG is a healthcare and blockchain investment firm based in Zug, Switzerland. BCM Europe is the founding organization behind Taekwondo Access Credit (TAC), a utility token adopted globally in the martial arts community and traded on centralized exchanges. Forward-Looking Statements This press release includes forward-looking statements regarding the expected timeline and design of the OSRT security token offering and BCM Europe's participation strategy. These statements are subject to risks and uncertainties, including but not limited to regulatory approvals, market volatility, and technical readiness. The OSRT Token offering has not yet been approved by the Board of OSR Holdings and will proceed only upon satisfaction of applicable legal and regulatory requirements. Contact Information OSR Holdings, Inc. Investor Relations [email protected] +82-31-948-9419 BCM Europe AG Media Relations [email protected] +41-41-725-0800 View original content to download multimedia: SOURCE OSR Holdings Inc.
Business Insider
29-05-2025
- Business
- Business Insider
OSR Holdings files to sell 15.41M shares of common stock for holders
17:25 EDT OSR Holdings (OSRH) files to sell 15.41M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
